Projects overview

Sort by


Toggle all information

RIGVIR | Feasibility study for registration of medicine RIGVIR with the European Medicine Agency

01-08-2016

-

31-01-2017

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

TYCHOBIO | Commercialization of high-value chemical production in moss

01-03-2017

-

31-08-2017

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

INDALG | Development of an innovative algae based tertiary wastewater treatment and value recovery system

01-10-2016

-

31-03-2019

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

USONIPRO | Ultrasonic technology for bioprocess enhancement

01-06-2016

-

31-10-2016

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

GAIT | From symptom relief to disease modifying allergy treatment with Glycan-Allergen Immunotherapy

01-03-2017

-

31-08-2017

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

BTech | Novel human neurodegenerative disease specific 3D cell-models with applications in drug development and toxicity testing

01-02-2018

-

31-05-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

N-IF | The N-IF mouse – a new and unique fibrosis model for preclinical efficacy studies

01-12-2017

-

31-05-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

GLUCOSTAT | Automatic Control of Blood Glucose Concentration for Intensive Care patients

01-11-2017

-

31-03-2022

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

MilliDrop | New MilliDrop Analyzer: miniaturized and faster clinical microbiology testing in only one drop

01-08-2017

-

31-01-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

RHYP | A new hope for early gonarthrosis treatment using a biotechnological therapeutic drug to regenerate cartilage by intra-articular knee injection

01-06-2017

-

30-11-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

FAST-BM | FAST-BM: FibroSelect: delivering A Step-change in Biotherapeutic Manufacturing

01-08-2016

-

31-12-2016

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

FLUSENSOR | FLUSENSOR - innovative, ultra-sensitive, fast and cheap micro-test to detect influenza virus

01-06-2016

-

30-11-2016

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

IMMOVA | Novel Immunotherapeutic Vaccine for the treatment of Alzheimer’s disease

01-03-2017

-

31-08-2017

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

HepaCheC | HepaCheC - an in vitro diagnostic assay for the early detection of liver cancer

01-02-2018

-

31-07-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

ULISENS | Ultra Legionella Inmunoanalysis System for Early Sensing

01-06-2016

-

31-05-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

SYNBIOMAN | Demonstration of a synthetic biology-driven biomanufacturing platform for adaptable cost-effective production of high-value low volume biologics opportunities.

01-08-2016

-

31-12-2016

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

JEM Phase 1 | JEM: The world safest subcutaneous, enclosed, biocompatible implantable device, attached directly to a AV fistula or graft or vein, for chronic disease patients in need of repetitive vascular access

01-06-2016

-

30-11-2016

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

OVOMATIC | IN-OVO AUTOMATION FOR CANCER DRUG DISCOVERY

01-01-2017

-

30-06-2017

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

SYN1002 | A New Therapeutic Option to Protect Central Nervous System against Acute Ischemic Stroke

01-08-2017

-

31-01-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

SSFENZYMES | Feasibility study for the implementation of the production of organic, granulated enzymes for detergent application by automated solid-state fermentation and fluidised-bed technology

01-12-2016

-

31-05-2017

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

SOS Jelly | An advanced biological remedy against jellyfish stings

01-06-2016

-

30-11-2016

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

ThromboSLE | Accurate assessment of thrombosis risk in systemic lupus erythematosus

01-03-2018

-

31-08-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

SynVaccine | Rational Design and Construction of Viral Based Products

01-06-2017

-

30-09-2017

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

FlexiBiome | Next Generation Microbiome Platform

01-04-2018

-

31-07-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

TCR | Feasibility Assessment on Thermal Catalytical Reforming

01-06-2016

-

31-10-2016

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

SINUSLIGHT | Laser-spectroscopic sensing device for diagnostic assessment of sinusitis

01-01-2018

-

30-06-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

AMPK-DIAB | A small molecule AMP activated protein kinase (AMPK) activator, denoted O304, as a novel innovative drug for the treatment of type 2 diabetes

01-11-2016

-

30-06-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

KERASTOP | A big jump in preventing problems in refractive surgery for myopia

01-06-2017

-

31-08-2017

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

SEQURE | Targeted complete next-generation sequencing for companion diagnostics and personalized treatment of cancer

01-05-2018

-

30-04-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market

INTACT | Imaging NM: A Nanoparticulate Precision Medicine Approach to Target Cancer

01-08-2017

-

30-06-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.4. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
H2020-SMEINST-1-2016-2017
SMEInst-03-2016-2017 Dedicated support to biotechnology SMEs closing the gap from lab to market
Powered by Chris Decubber BV